ABSTRACT Sarcopenia of aging is not explained entirely on the basis of age-associated reduced physical activity. Progressive neuromuscular changes and diminishing anabolic hormone levels are thought to contribute to the pathogenesis of sarcopenia. Decline in muscle mass indicates a decline in muscle protein content. Recent studies demonstrated an age-related decline in synthesis rate of mixed muscle proteins, myosin heavy chain and mitochondrial protein. Reductions in myosin heavy chain and mitochondrial protein synthesis rates have been correlated with age-associated decrements in muscle strength and aerobic exercise tolerance, respectively. These changes have been reported as early as 50 y of age and are related to the decline in insulin-like growth factor (IGF)-I, testosterone and dehydroepiandrosterone (DHEA)-sulfate. The declining ability to remodel these important muscle proteins may therefore play a role in the development of muscle wasting, metabolic abnormalities and impaired physical functioning seen in old age.
Normal aging in humans is associated with declines in skel- Tseng et al. 1995) . However, even highly trained (10-20 etal muscle mass and strength and increased muscle fatigability y) older athletes do not maintain muscle function or body (sarcopenia). These changes, together with the age-associated composition at the levels seen in physically active young subdecline in whole-body exercise tolerance (VO 2max ), can subjects (Klitgaard et al. 1990 ). These findings suggest that there stantially reduce the amount and intensity of physical activiare some irreversible physiologic changes associated with aging ties performed by elderly (ú60 y) men and women (Evans per se that lead to sarcopenia in older humans. These age-1995). Moreover, the effects of reduced muscle mass and physidependent alterations are thought to result from diminished cal activity levels with advancing age substantially reduce daily levels of anabolic hormones and progressive neuromuscular energy expenditure among older people (Goran and Poehlman alterations (Lexell et al. 1988, Rudman et al. 1991) . However, 1992) . Decreased daily energy expenditure is thought to be there is also a general decline in muscle protein turnover with involved in the age-associated accumulation of visceral and advancing age (Nair 1995) . This review describes the agetotal body fat, which in turn is a risk factor for the development associated changes in human skeletal muscle mass and funcof type II diabetes (Holloszy and Kohrt 1995) . These physical tion, and the related alterations in synthesis rates of specific and metabolic impairments associated with sarcopenia are remuscle proteins. The potential effects of anabolic hormone ducing the quality of life for a rapidly expanding older populareplacement on muscle mass, function and protein synthesis tion (Dutta and Hadley 1995) .
in the elderly are also discussed. There is accumulating evidence that physically active older people maintain higher levels of muscle mass and function, CHANGES IN SKELETAL MUSCLE MASS AND and develop less central adiposity and insulin resistance with FUNCTION WITH AGING aging than their sedentary peers (Holloszy and Kohrt 1995, Aging is associated with reductions in fat-free mass (FFM), 4 total body potassium and urinary creatinine excretion, each (Kallman et al. 1990 ) and findings in old mice and rats, in which precise estimates of limb muscle specific force are reduced by as much as 20% (Brooks and Faulkner 1994) . Additional studies are required to resolve this somewhat confusing area. Aging also reduces the peak forces that can be generated by muscles at fast contraction speeds and the speed at which the activated muscles can relax (Overend et al. 1992 ). These physiologic changes, which are possibly related to shifts in myosin isoform composition, have important implications for peak and sustainable power output capacities of skeletal muscle. The importance of understanding the mechanisms underlying these particular muscle properties is supported by the close association between age-related reductions in lower extremity power output and functional abilities such as maximal walking speed and stair climbing ability (Hurley 1995) . This reduced capacity for rapid force generation might also limit FIGURE 1 Changes in the muscle/body weight ratio with aging in the ability to respond quickly to a loss of balance and increase healthy men and women (estimated from Fleg and Lakatta 1988) .
the risk of falling. muscle mass appear to be similar (Going et al. 1995) . Based AGING AND MUSCLE PROTEIN DYNAMICS on cross-sectional data, the loss of skeletal muscle mass is substantial, amounting to 35-40% between 20 and 80 y of After excluding water, protein is the major component of skeletal muscle, accounting for Ç20% of muscle weight. age (Evans 1995, Fleg and Lakatta 1988) . Muscle loss also accounts for most of the loss of body protein with aging (Cohn Therefore, changes in muscle mass should reflect an imbalance between removal of old and damaged muscle proteins (breaket al. 1980 ). The muscle:body weight ratio declines progressively with age ( Fig. 1) . These losses of muscle mass and prodown) and synthesis of new ones (Nair 1995). To understand the biochemical basis for sarcopenia, investigators have comtein with advancing age do not typically result in weight loss because there is a corresponding accumulation of body fat.
pared whole-body protein synthesis and breakdown rates in subjects of different ages. However, whole-body protein turnThe decline of muscle mass with aging results in large part from the loss of individual muscle fibers. Additionally, there over measurements are inappropriate for determining small changes in muscle protein synthesis and breakdown because seems to be a preferential atrophy of fast-twitch (type II) fibers. These changes have been shown by counting individual fibers muscle contributes õ30% to the whole-body protein turnover rate (Nair 1995). However, fractional synthesis rates of mixed in whole-muscle cross-sections from cadavers of various ages (Lexell et al. 1988 ). The proportions (%) of histochemical or myofibrillar protein from muscle biopsy samples are reduced in older humans (Welle et al. 1993 , Yarasheski et al. 1993 ). type I (slow-twitch) and type II fibers are relatively stable across age, suggesting that roughly equal numbers of slow-and Because there is no conclusive evidence of accelerated muscle protein breakdown in healthy older people (Nair 1995), these fast-twitch fibers are lost. However, as a result of the greater atrophy and reduced reinnervation capacity of fast-twitch fifindings suggest that aging is associated with a reduced capacity of skeletal muscle to synthesize new proteins. This imbalance bers in older muscle tissue (Tseng et al. 1995) , there is likely to be a proportionally greater loss of type II myosin from skeletal ultimately leads to reduced muscle mass and protein content. The synthesis rate of mixed muscle protein represents an muscles with advancing age. These changes, together with increases in intramuscular fat and connective tissue (Frontera average value of all the individual proteins found within the muscle cell (mitochondrial, myofibrillar, sarcoplasmic and inet al. 1991, Overend et al. 1992) , reduce the contractile tissue volume (particularly type II myosin isoforms) available for tracellular matrix proteins). These different protein fractions and their individual component proteins have specific functhe important locomotive and metabolic functions of skeletal muscle.
tions and reportedly different synthesis rates . Therefore, a better understanding of the mechanisms Summary of muscle functional changes with aging. Muscular strength is typically maintained at peak levels until the leading to reduced muscle mass and function in old age is likely to be obtained by examining synthetic rates of these fifth or sixth decade, after which accelerated losses occur (Hurley 1995). The age-associated reduction of quadriceps muscle individual muscle proteins. This approach has been difficult in humans due to the need for large quantities of muscle. strength is such that the average 80-y-old is at or near the minimum level of strength required to rise from a chair (ReynHowever, the techniques recently developed in our laboratory for purifying individual muscle proteins and measuring their olds and Garrett 1989). Leg muscle strength also appears to be related to maximum (Conley et al. 1995) and sustainable isotopic enrichment have enabled such investigations to be initiated , Rooyackers et al. 1996 . Pre- (Ades et al. 1996) walking speeds in ambulatory older populations. Declines in maximal muscle strength could result from liminary studies have revealed that the synthesis rate of myosin heavy chain, a major structural protein that is responsible the loss of muscle mass, reductions in the intrinsic contractile properties (i.e., specific force) of the remaining fibers or to a together with actin for ATP hydrolysis (ATPase activity), is significantly reduced in middle-aged (31%) and older (44%) reduced ability to activate the muscle maximally. In the proximal limb muscles of humans (i.e., knee/elbow flexors and exmen and women ). Protein turnover is not only critical for maintaining the tensors), a major cause of age-associated maximal strength losses appears to be the reduced cross-sectional area of the integrity of structural and contractile proteins such as myosin, but is also necessary for maintaining other functional units active muscle tissue (Conley et al. 1995 , Evans 1995 . This is shown for the quadriceps muscle group in Figure 2 . However, such as enzymes. Rooyackers et al. (1996) recently reported a pronounced decline (40%) in mitochondrial protein synthesis this is in apparent contrast with studies of small muscle groups rates of middle-aged (54 { 1 y) subjects, but no further deThus, additional study of specific muscle proteins should prove helpful in determining the mechanistic role that dimincrease in seven elderly (73 { 2 y) subjects. This finding, which is shown in Figure 3 , is intriguing because mitochondrial enished GH secretion plays in the body composition and functional changes that occur with advancing age. zyme activities typically continue to decline beyond middle age. The reduced enzyme activities in old age could be exGrowth hormone exposure invariably leads to increases in the levels of IGF-I. IGF-I has anabolic properties and is replained by a reduced mitochondrial protein synthesis, possibly resulting from an increase in mitochondrial DNA mutations ported to preferentially stimulate muscle protein synthesis (Fryburg et al. 1995) when administered locally. The mechawith aging. These findings are significant not only for agerelated changes in muscular endurance and fatigability, but nism and role of IGF-I (free vs. total) and the importance of individual binding proteins in sarcopenia remain to be estabalso for ATP requirements associated with the synthesis of lished. other muscle proteins.
Although age-related osteoporosis and sarcopenia have been associated with a decline in testosterone levels in men, HORMONAL CHANGES AND THEIR the effects of testosterone replacement on muscle mass, RELATIONSHIP TO SARCOPENIA strength and metabolism in older men are poorly defined. For Normal aging results in decreased circulating levels of sevexample, Tenover (1992) administered testosterone intramuseral anabolic hormones that may contribute to the changes in cularly to older men age 57-76 y for 3 mo and demonstrated muscle mass and function seen in older people (Tenover an increase in FFM, but no change in grip strength, whereas 1992). The major anabolic hormone changes that occur with Morley et al. (1993) found exactly the opposite results in advancing age are highlighted in Table 1. hypogonadal males. Urban et al. (1995) recently reported inProgressive declines in growth hormone (GH) secretion creased muscle strength and mixed muscle protein synthesis and plasma insulin-like growth factor (IGF )-I levels with after testosterone administration in a small group of elderly advancing age have been suggested as possible mechanisms men. Therefore, the effects of testosterone on age-related sarfor the body composition changes with aging. In support of copenia remain to be clearly defined. It is also unclear what this hypothesis, Rudman et al. (1991) reported that older effect testosterone replacement might have on prostate cancer (ú61 y) men who received GH injections for 18 months risk. increased their FFM by 6% while decreasing fat mass by 15%.
The decline in dehydroepiandrosterone (DHEA) with Direct evidence of muscle size increases with GH administraaging coincides with the development of other age-related tion has been reported recently in two studies of healthy changes including sarcopenia and related metabolic disorders. older men and women (Butterfield et al. 1997, Welle et al. Although several studies have failed to document physiologic 1996). However, the findings of these two studies differed effects in healthy young individuals, administration of DHEA with respect to muscle protein synthesis. Butterfield et al. seems to work more effectively in older men and women (Yen (1997) reported a significant increase in mixed muscle proet al. 1995) . In the studies on older subjects, DHEA administein synthesis with GH treatment, whereas Welle et al. tration increased DHEA blood levels and increased biologi-(1996) failed to show an increase in myofibrillar protein syncally active IGF-I (Yen et al. 1995) , which has been shown thesis. The exact reasons for this discrepancy are unclear.
to stimulate muscle protein synthesis in humans (Fryburg et However, it is possible that GH-induced protein accretion al. 1995) . However, the number of older subjects studied to occurs within specific proteins and may not be reflected in date is rather small, and the mechanism underlying DHEA's effects on muscle metabolism remains unclear. measurements of synthetic rates of mixed muscle proteins. pathophysiology of sarcopenia is the crucial first step toward developing rational therapeutic or preventative measures to address this problem. Declining physical activities and lifestyles may play an important role in the pathogenesis of sarcopenia. Aging is also associated with declines in the levels and actions of many anabolic hormones and with reduced synthetic rates of key contractile (myosin heavy chain) and metabolic (mitochondrial) proteins. Future research is required to understand whether the replacement of hormones such as DHEA and testosterone will provide benefits that sufficiently exceed the potential risks. Such therapeutic trials should adopt a mechanistic approach, with careful attention focused on the benefit-risk ratio.
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